How NewcelX Ltd. is pursuing durable islet graft survival in the race for a functional diabetes cure
How NewcelX Ltd. is advancing NCEL-101 toward a functional diabetes cure through durable islet graft survival and immune protection strategies.
Pharma & Biotech
Pharma & Biotech
Is DOXA the multi-mechanism small molecule NewcelX needs for narcolepsy and ALS?
NewcelX Ltd. has announced the publication of its international DOXA compound patent in China, further securing intellectual property protection for its cross-domain pipeline in neurology and metabolic diseases. The patent application covers a new class of small molecules derived from quinazoline, benzothiazine, and benzoxazine scaffolds. These compounds are designed to modulate orexin signaling, neuroinflammation, and